TLR4 enhances TGF-β signaling and hepatic fibrosis

Nature Medicine

Volumn 13, Issue 11, 2007, Pages 1324-1332

  Seki, Ekihiro ^a,b   De Minicis, Samuele ^a,b   Österreicher, Christoph H ^a,b   Kluwe, Johannes ^a   Osawa, Yosuke ^a   Brenner, David A ^b   Schwabe, Robert F ^a  

^a College of Physicians and Surgeons ^*  (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL FLORA; CELL ACTIVATION; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE RELEASE; FIBROGENESIS; HEPATITIS; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INTESTINE FLORA; KUPFFER CELL; LIVER CELL; LIVER FIBROSIS; MALE; MOUSE; MYOFIBROBLAST; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; STELLATE CELL; STEM CELL; WESTERN BLOTTING;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; CELL COMMUNICATION; CELLS, CULTURED; COMMON BILE DUCT; INTESTINAL MUCOSA; LIGATION; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MYELOID DIFFERENTIATION FACTOR 88; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

BACTERIA (MICROORGANISMS); MUS;

EID: 35948958955     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1663     Document Type: Article

References (47)

1. Bataller, R. & Brenner, D.A. Liver fibrosis. J. Clin. Invest. 115, 209-218 (2005).
2. Friedman, S.L. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J. Biol. Chem. 275, 2247-2250 (2000).
3. Akira, S. & Takeda, K. Toll-like receptor signalling. Nat. Rev. Immunol. 4, 499-511 (2004).
4. Jiang, D. et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat. Med. 11, 1173-1179 (2005).
5. Bjorkbacka, H. et al. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat. Med. 10, 416-421 (2004).
6. Zhai, Y. et al. Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J. Immunol. 173, 7115-7119 (2004).
7. Tsung, A. et al. Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells. J. Immunol. 175, 7661-7668 (2005).
8. Uesugi, T., Froh, M., Arteel, G.E., Bradford, B.U. & Thurman, R.G. Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice. Hepatology 34, 101-108 (2001).
9. Seki, E. et al. Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration. Hepatology 41, 443-450 (2005).
10. Schwabe, R.F., Seki, E. & Brenner, D.A. Toll-like receptor signaling in the liver. Gastroenterology 130, 1886-1900 (2006).
11. Seki, E. et al. Lipopolysaccharide-induced IL-18 secretion from murine Kupffer cells independently of myeloid differentiation factor 88 that is critically involved in induction of production of IL-12 and IL-1β. J. Immunol. 166, 2651-2657 (2001).
12. Duffield, J.S. et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J. Clin. Invest. 115, 56-65 (2005).
13. 3 treatment or dietary glycine. Am. J. Physiol. Gastrointest. Liver Physiol. 281, G200-G207 (2001).
14. Paik, Y.H. et al. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology 37, 1043-1055 (2003).
15. Brun, P., Castagliuolo, I., Pinzani, M., Palu, G. & Martines, D. Exposure to bacterial cell wall products triggers an inflammatory phenotype in hepatic stellate cells. Am. J. Physiol. Gastrointest. Liver Physiol. 289, G571-G578 (2005).
16. Muhlbauer, M. et al. LPS-mediated NF-κB activation varies between activated human hepatic stellate cells from different donors. Biochem. Biophys. Res. Commun. 325, 191-197 (2004).
17. Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S. & Medzhitov, R. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118, 229-241 (2004).
18. Magilavy, D.B. & Rothstein, J.L. Spontaneous production of tumor necrosis factor alpha by Kupffer cells of MRL/lpr mice. J. Exp. Med. 168, 789-794 (1988).
19. Yata, Y. et al. DNase I-hypersensitive sites enhance alpha1(I) collagen gene expression in hepatic stellate cells. Hepatology 37, 267-276 (2003).
20. Onichtchouk, D. et al. Silencing of TGF-β signalling by the pseudoreceptor Bambi. Nature 401, 480-485 (1999).
21. Iimuro, Y. et al. NF-κB prevents apoptosis and liver dysfunction during liver regeneration. J. Clin. Invest. 101, 802-811 (1998).
22. Maeda, S., Kamata, H., Luo, J.L., Leffert, H. & Karin, M. IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 121, 977-990 (2005).
23. Pikarsky, E. et al. NF-κB functions as a tumour promoter in inflammation-associated cancer. Nature 431, 461-466 (2004).
24. Isogawa, M., Robek, M.D., Furuichi, Y. & Chisari, F.V. Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. J. Virol. 79, 7269-7272 (2005).
25. Izuishi, K. et al. Cutting edge: high-mobility group box 1 preconditioning protects against liver ischemia-reperfusion injury. J. Immunol. 176, 7154-7158 (2006).
26. Lotze, M.T. & Tracey, K.J. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 5, 331-342 (2005).
27. Termeer, C. et al. Oligosaccharides of hyaluronan activate dendritic cells via Toll-like receptor 4. J. Exp. Med. 195, 99-111 (2002).
28. Tsung, A. et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J. Exp. Med. 201, 1135-1143 (2005).
29. Isayama, F. et al. LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 290, G1318-G1328 (2006).
30. Friedman, S.L. & Arthur, M.J. Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors. J. Clin. Invest. 84, 1780-1785 (1989).
31. De Minicis, S. et al. Gene expression profiles during hepatic stellate cell activation in culture and in vivo. Gastroenterology 132, 1937-1946 (2007).
32. Sasaki, T., Sasahira, T., Shimura, H., Ikeda, S. & Kuniyasu, H. Effect of Nma on growth inhibition by TGF-β in human gastric carcinoma cell lines. Oncol. Rep. 11, 1219-1223 (2004).
33. Tsang, M. et al. Zebrafish nma is involved in TGF-β family signaling. Genesis 28, 47-57 (2000).
34. Sekiya, T. et al. Identification of BMP and activin membrane-bound inhibitor (Bambi), an inhibitor of transforming growth factor-β signaling, as a target of the β-catenin pathway in colorectal tumor cells. J. Biol. Chem. 279, 6840-6846 (2004).
35. Sekiya, T., Oda, T., Matsuura, K. & Akiyama, T. Transcriptional regulation of the TGF-β pseudoreceptor Bambi by TGF-β signaling. Biochem. Biophys. Res. Commun. 320, 680-684 (2004).
36. Oakley, F. et al. Inhibition of inhibitor of κB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis. Gastroenterology 128, 108-120 (2005).
37. Thurman, R.G. et al. The role of gut-derived bacterial toxins and free radicals in alcohol-induced liver injury. J. Gastroenterol. Hepatol. 13 Suppl, S39-S50 (1998).
38. Diehl, A.M., Li, Z.P., Lin, H.Z. & Yang, S.Q. Cytokines and the pathogenesis of nonalcoholic steatohepatitis. Gut 54, 303-306 (2005).
39. Campbell, J.S. et al. Proinflammatory cytokine production in liver regeneration is Myd88-dependent, but independent of Cd14, Tlr2, and Tlr4. J. Immunol. 176, 2522-2528 (2006).
40. Huang, H. et al. A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C. Hepatology, 46, 297-306 (2007).
41. Hoebe, K. et al. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 424, 743-748 (2003).
42. Adachi, O. et al. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9, 143-150 (1998).
43. Kisseleva, T. et al. Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J. Hepatol. 45, 429-438 (2006).
44. Kennedy, D.W. & Abkowitz, J.L. Kinetics of central nervous system microglial and macrophage engraftment: analysis using a transgenic bone marrow transplantation model. Blood 90, 986-993 (1997).
45. Van Rooijen, N. & Sanders, A. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J. Immunol. Methods 174, 83-93 (1994).
46. Bataller, R. et al. NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J. Clin. Invest. 112, 1383-1394 (2003).
47. Siegmund, S.V., Uchinami, H., Osawa, Y., Brenner, D.A. & Schwabe, R.F. Anandamide induces necrosis in primary hepatic stellate cells. Hepatology 41, 1085-1095 (2005).